Comparative effectiveness research: policy and politics

2012 ◽  
Vol 33 (1) ◽  
pp. E6 ◽  
Author(s):  
Edie E. Zusman

Comparative effectiveness research (CER) is the basis for some of the fiercest rhetoric of the current political era. While it is a relatively old and previously academic pursuit, CER may well become the foundation upon which the future of health care in the US is based. The actual impact of CER on—and uptake among—doctors, patients, hospitals, and health insurers, however, remains to be seen. Political considerations and compromises have led to the removal of key aspects of CER implementation from policy legislation to prevent alienating stakeholders critical to the success of health care reform. Health care providers, including specialists such as neurosurgeons, will need to understand both the policies and political implications of CER as its practices becomes an indelible part of the future health care landscape.

2012 ◽  
Vol 33 (1) ◽  
pp. E7 ◽  
Author(s):  
Laura P. D'Arcy ◽  
Eugene C. Rich

Containing growth in health care expenditures is considered to be essential to improving both the long-term fiscal outlook of the federal government and the future affordability of health care in the US. As health care expenditures have increased, so too have concerns about the quality of health care. Better information on the clinical effectiveness of alternative treatments and other interventions is needed to improve the quality of care and restrain growth in expenditures. This article explains the key role played by the federal government in defining the context and process of comparative effectiveness research as well as its funding. Subsequently, the article explores the mission, priorities, and research agenda of the Patient-Centered Outcomes Research Institute, which is an independent, nonprofit corporation established in 2010 by the Patient Protection and Affordable Care Act.


2020 ◽  
Vol 46 ◽  
pp. 22-29
Author(s):  
Penni I. Watts ◽  
Todd Peterson ◽  
Michelle Brown ◽  
Dawn Taylor Peterson ◽  
Tracie White ◽  
...  

Author(s):  
Harvey Max Chochinov ◽  
Susan E. McClement ◽  
Maia S. Kredentser

The concept of dignity continues to receive attention in health care, with particular implications for end-of-life care. This chapter reviews current conceptualizations of dignity, integrating medical, philosophical, and ontological perspectives. The centrality of dignity to palliative care is discussed, exploring empirical findings, which examine what dignity means to patients and families in the context of illness and end-of-life care. The chapter provides an overview of validated tools, evidence-based therapies, and practical ‘everyday’ communication skills that health-care providers in diverse clinical settings can use to enhance patient dignity. Suggestions are provided for extending existing research into the notion of dignity as it relates to vulnerable groups, and how interventions aimed at supporting patient dignity can impact family members. Dignity subsumes many key aspects of comprehensive care, which can guide health-care providers towards improving end-of-life experiences for patients and families.


2017 ◽  
Vol 16 (4) ◽  
pp. 606-609 ◽  
Author(s):  
Rabeya Yousuf ◽  
Sheikh Muhammad Abu Bakar ◽  
Mainul Haque ◽  
Md Nurul Islam ◽  
Abdus Salam

Social media connect people by sharing text, photos, audio and videos among themselves. Medical professional and patients also communicate through social media; however, issues of privacy and confidentiality of medical professions in regards to medical and health care decisions contradict with the openness of the usage of social media. Member of the medical profession can use social media but need to abide by the code of conduct of medical ethics in order to render the best possible services. This paper emphasizes on the needs of inclusion of social media usage in future health care providers’ curriculum by the higher educational institutions in order to aware of the ethical and professional aspect.Bangladesh Journal of Medical Science Vol.16(4) 2017 p.606-609


2012 ◽  
Vol 30 (34) ◽  
pp. 4194-4201 ◽  
Author(s):  
Olwen M. Hahn ◽  
Richard L. Schilsky

Comparative effectiveness research (CER) has been promoted as a way to improve the translation gap between clinical research and everyday clinical practice as well as to deliver more cost-effective health care. CER will account for a significant portion of funding allocated by the US government for health care research. Oncology has a rich history of improving clinical outcomes and advancing research through randomized controlled trials (RCTs). In this article, we review the role of RCTs in achieving the goals of CER, with particular emphasis on the role of publicly funded clinical trials.


Sign in / Sign up

Export Citation Format

Share Document